Aprea Therapeutics, Inc. (APRE) Capital expenditures 2019–2025
Aprea Therapeutics, Inc. (APRE) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$15,478FY2025 · since FY2019: $3,702 → $15,478
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $15,478 | -83.4% |
| FY2024 | $93,093 | — |
| FY2021 | $25,709 | -16.8% |
| FY2020 | $30,901 | +734.7% |
| FY2019 | $3,702 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice